These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33429029)

  • 1. COVID-19 case fatality rates can be highly misleading in resource-poor and fragile nations: the case of Yemen.
    Noushad M; Al-Saqqaf IS
    Clin Microbiol Infect; 2021 Apr; 27(4):509-510. PubMed ID: 33429029
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19: Is herd immunity the only option for fragile Yemen?
    Noushad M; Al-Saqqaf IS
    Int J Infect Dis; 2021 May; 106():79-82. PubMed ID: 33737135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Healthcare System Capabilities and Preparedness in Yemen to Confront the Novel Coronavirus 2019 (COVID-19) Outbreak: A Perspective of Healthcare Workers.
    Zawiah M; Al-Ashwal FY; Saeed RM; Kubas M; Saeed S; Khan AH; Sulaiman SAS; Abduljabbar R
    Front Public Health; 2020; 8():419. PubMed ID: 32850608
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of laboratory testing on COVID-19 monitoring indicators: an analysis of the 50 countries with the highest number of cases.
    Pilecco FB; Coelho CG; Fernandes QHRF; Silveira IH; Pescarini JM; Ortelan N; Gabrielli L; Aquino EML; Barreto ML
    Epidemiol Serv Saude; 2021; 30(2):e2020722. PubMed ID: 34008747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the massive underreporting and undertesting of COVID-19 cases in multiple global epicenters.
    Lau H; Khosrawipour T; Kocbach P; Ichii H; Bania J; Khosrawipour V
    Pulmonology; 2021; 27(2):110-115. PubMed ID: 32540223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Need for Standardized Metrics to Drive Decision-making During the COVID-19 Pandemic.
    Austin JM; Kachalia A
    J Hosp Med; 2021 Jan; 16(1):56-58. PubMed ID: 33357331
    [No Abstract]   [Full Text] [Related]  

  • 7. National case fatality rates of the COVID-19 pandemic.
    Ergönül Ö; Akyol M; Tanrıöver C; Tiemeier H; Petersen E; Petrosillo N; Gönen M
    Clin Microbiol Infect; 2021 Jan; 27(1):118-124. PubMed ID: 32979575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating COVID-19‒ Related Mortality in India: An Epidemiological Challenge With Insufficient Data.
    Zimmermann LV; Salvatore M; Babu GR; Mukherjee B
    Am J Public Health; 2021 Jul; 111(S2):S59-S62. PubMed ID: 34314196
    [No Abstract]   [Full Text] [Related]  

  • 9. Open letter to Chris Whitty and Susan Hopkins: change covid-19 case definition in line with WHO to save lives.
    Sohal A
    BMJ; 2021 Jan; 372():n283. PubMed ID: 33514502
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 in the MENA Region: Facts and Findings.
    Younis NK; Rahm M; Bitar F; Arabi M
    J Infect Dev Ctries; 2021 Mar; 15(3):342-349. PubMed ID: 33839707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-country evidence on the association between contact tracing and COVID-19 case fatality rates.
    Yalaman A; Basbug G; Elgin C; Galvani AP
    Sci Rep; 2021 Jan; 11(1):2145. PubMed ID: 33495491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 in Germany: Association between deaths and positive rate.
    Scherb H
    Eur J Clin Invest; 2021 Apr; 51(4):e13500. PubMed ID: 33497463
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of population mortality of COVID-19 and testing coverage: a comparison among 36 OECD countries.
    Wei C; Lee CC; Hsu TC; Hsu WT; Chan CC; Chen SC; Chen CJ
    Epidemiol Infect; 2020 Dec; 149():e1. PubMed ID: 33413705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated Impact of Public and Private Sector COVID-19 Diagnostics and Treatments on US Healthcare Resource Utilization.
    Sheinson DM; Wong WB; Solon CE; Cheng MM; Shah A; Elsea D; Meng Y
    Adv Ther; 2021 Feb; 38(2):1212-1226. PubMed ID: 33367984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 pandemic in Yemen: A questionnaire based survey, what do we know?
    Dhabaan G; Chahin A; Buhaish A; Shorman M
    J Infect Dev Ctries; 2020 Dec; 14(12):1374-1379. PubMed ID: 33378278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What does COVID-19 testing results really say? The real statistics concealed behind the accessible data.
    Rashki A; Hoseinpour Dehkordi A; Nemati R; Tavousi P
    J Med Virol; 2021 Oct; 93(10):5977-5987. PubMed ID: 34224155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of COVID-19 epidemiological indicators in Sweden, Norway, Denmark, and Finland.
    Yarmol-Matusiak EA; Cipriano LE; Stranges S
    Scand J Public Health; 2021 Feb; 49(1):69-78. PubMed ID: 33413051
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of an Online Tool to Simulate the Effect of Pooled Testing for SARS-CoV-2 Detection in Asymptomatic and Symptomatic Populations.
    Polage CR; Lee MJ; Hubbard C; Rehder C; Cardona D; Denny T; Datto MB
    JAMA Netw Open; 2020 Dec; 3(12):e2031517. PubMed ID: 33301014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy in Measuring Racial Disparities during the COVID-19 Pandemic Needs Improvement.
    Patel AGM; Hsiao CJ; Fasanya HO; Stoffel M; Lyon ME
    J Appl Lab Med; 2021 Jan; 6(1):310-313. PubMed ID: 33300994
    [No Abstract]   [Full Text] [Related]  

  • 20. Testing for COVID-19 cases in ASEAN.
    Koh DS; Wong SX; Wong J
    Western Pac Surveill Response J; 2020; 11(4):43-45. PubMed ID: 34046242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.